Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study
Titel:
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study
Auteur:
Valle, Juan W Vogel, Arndt Denlinger, Crystal S He, Aiwu Ruth Bai, Li-Yuan Orlova, Rashida Van Cutsem, Eric Adeva, Jorge Chen, Li-Tzong Obermannova, Radka Ettrich, Thomas J Chen, Jen-Shi Wasan, Harpreet Girvan, Allicia C Zhang, Wei Liu, Jiangang Tang, Chunlao Ebert, Philip J Aggarwal, Amit McNeely, Samuel C Moser, Brian A Oliveira, Joana M Carlesi, Roberto Walgren, Richard A Oh, Do-Youn